Mesenchymal stem cell basic research and applications in dog medicine
The stem cells, owing to their special characteristics like self‐renewal, multiplication,
homing, immunomodulation, anti‐inflammatory, and dedifferentiation are considered to carry …
homing, immunomodulation, anti‐inflammatory, and dedifferentiation are considered to carry …
[HTML][HTML] Challenges of stem cell therapies in companion animal practice
MH Kang, HM Park - Journal of Veterinary Science, 2020 - ncbi.nlm.nih.gov
Regenerative medicine using stem cells from various sources are emerging treatment
modality in several refractory diseases in veterinary medicine. It is well-known that stem cells …
modality in several refractory diseases in veterinary medicine. It is well-known that stem cells …
[HTML][HTML] A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019
W Da, Z Tao, Y Meng, K Wen, S Zhou, K Yang, L Tao - BMC cancer, 2021 - Springer
Background In recent decades, the 5-year survival rate of osteosarcoma remains poor,
despite the variety of operations, and exploration of drug therapy has become the key to …
despite the variety of operations, and exploration of drug therapy has become the key to …
Dog Mesenchymal Stem Cell Basic Research and Potential Applications
MB Gugjoo, A Pal, GT Sharma - Mesenchymal Stem Cell in Veterinary …, 2020 - Springer
Mesenchymal stem cells (MSCs) being available in numerous adult tissues and foetal
membranes have been harvested from almost all these sources in dog. Due to the presence …
membranes have been harvested from almost all these sources in dog. Due to the presence …
Effects of luteolin on canine osteosarcoma: suppression of cell proliferation and synergy with cisplatin
Canine osteosarcoma is characterized by aggressiveness, easy metastasis to the lungs, and
high mortality after standard therapy. Luteolin is a flavonoid found in vegetables and fruits …
high mortality after standard therapy. Luteolin is a flavonoid found in vegetables and fruits …
[HTML][HTML] To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein's Role in …
C Xu, M Wang, B Zandieh-Doulabi, W Sun… - Frontiers in cell and …, 2021 - frontiersin.org
Osteosarcoma (OS), a primary malignant bone tumor, stems from bone marrow-derived
mesenchymal stem cells (BMSCs) and/or committed osteoblast precursors. Distant …
mesenchymal stem cells (BMSCs) and/or committed osteoblast precursors. Distant …
[PDF][PDF] To B (Bone Morphogenetic Protein-2) or Not to B (Bone Morphogenetic Protein-2): Mesenchymal Stem Cells May Explain the Protein's Role in …
C Xu - VU Research Portal, 2024 - research.vu.nl
Osteosarcoma (OS), a primary malignant bone tumor, stems from bone marrow-derived
mesenchymal stem cells (BMSCs) and/or committed osteoblast precursors. Distant …
mesenchymal stem cells (BMSCs) and/or committed osteoblast precursors. Distant …
[引用][C] Respuesta ante la combinación terapéutica de quimioterapia, radioterapia e inmunoterapia en un paciente canino Labrador Retriever con osteosarcoma …
MA Ordóñez Avila - 2021 - Quito